|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Reilly EM and Abou-Alfa GK: Cytotoxic
therapy for advanced pancreatic adenocarcinoma. Semin Oncol.
34:347–353. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang Z, Li Y, Ahmad A, Banerjee S, Azmi
AS, Kong D and Sarkar FH: Pancreatic cancer: Understanding and
overcoming chemoresistance. Nat Rev Gastroenterol Hepatol. 8:27–33.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bergman AM, Pinedo HM and Peters GJ:
Determinants of resistance to 2′,2′-difluorodeoxycytidine
(gemcitabine). Drug Resist Updat. 5:19–33. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andersson R, Aho U, Nilsson BI, Peters GJ,
Pastor-Anglada M, Rasch W and Sandvold ML: Gemcitabine
chemoresistance in pancreatic cancer: Molecular mechanisms and
potential solutions. Scand J Gastroenterol. 44:782–786. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Polyak K and Hahn WC: Roots and stems:
Stem cells in cancer. Nat Med. 12:296–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kakarala M and Wicha MS: Implications of
the cancer stem-cell hypothesis for breast cancer prevention and
therapy. J Clin Oncol. 26:2813–2820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
10
|
Abdullah LN and Chow EK: Mechanisms of
chemoresistance in cancer stem cells. Clin Transl Med. 2:32013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ucar D, Cogle CR, Zucali JR, Ostmark B,
Scott EW, Zori R, Gray BA and Moreb JS: Aldehyde dehydrogenase
activity as a functional marker for lung cancer. Chem Biol
Interact. 178:48–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jimeno A, Feldmann G, Suárez-Gauthier A,
Rasheed Z, Solomon A, Zou GM, Rubio-Viqueira B, García-García E,
López-Ríos F, Matsui W, et al: A direct pancreatic cancer xenograft
model as a platform for cancer stem cell therapeutic development.
Mol Cancer Ther. 8:310–314. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hellsten R, Johansson M, Dahlman A,
Sterner O and Bjartell A: Galiellalactone inhibits stem cell-like
ALDH-positive prostate cancer cells. PLoS One. 6:e221182011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma S, Chan KW, Lee TK, Tang KH, Wo JY,
Zheng BJ and Guan XY: Aldehyde dehydrogenase discriminates the
CD133 liver cancer stem cell populations. Mol Cancer Res.
6:1146–1153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clay MR, Tabor M, Owen JH, Carey TE,
Bradford CR, Wolf GT, Wicha MS and Prince ME: Single-marker
identification of head and neck squamous cell carcinoma cancer stem
cells with aldehyde dehydrogenase. Head Neck. 32:1195–1201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yin T, Wei H, Gou S, Shi P, Yang Z, Zhao G
and Wang C: Cancer stem-like cells enriched in Panc-1 spheres
possess increased migration ability and resistance to gemcitabine.
Int J Mol Sci. 12:1595–1604. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiao F, Hu H, Han T, Yuan C and Wang L,
Jin Z, Guo Z and Wang L: Long noncoding RNA MALAT-1 enhances stem
cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci.
16:6677–6693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhuang Y, Wang X, Nguyen HT, Zhuo Y, Cui
X, Fewell C, Flemington EK and Shan B: Induction of long intergenic
non-coding RNA HOTAIR in lung cancer cells by type I collagen. J
Hematol Oncol. 6:352013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang A, Zhao JC, Kim J, Fong KW, Yang YA,
Chakravarti D, Mo YY and Yu J: LncRNA HOTAIR enhances the
androgen-receptor-mediated transcriptional program and drives
castration-resistant prostate cancer. Cell Rep. 13:209–221. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim K, Jutooru I, Chadalapaka G, Johnson
G, Frank J, Burghardt R, Kim S and Safe S: HOTAIR is a negative
prognostic factor and exhibits pro-oncogenic activity in pancreatic
cancer. Oncogene. 32:1616–1625. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tahira AC, Kubrusly MS, Faria MF, Dazzani
B, Fonseca RS, Maracaja-Coutinho V, Verjovski-Almeida S, Machado MC
and Reis EM: Long noncoding intronic RNAs are differentially
expressed in primary and metastatic pancreatic cancer. Mol Cancer.
10:1412011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee CJ, Dosch J and Simeone DM: Pancreatic
cancer stem cells. J Clin Oncol. 26:2806–2812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hermann PC, Mueller MT and Heeschen C:
Pancreatic cancer stem cells-insights and perspectives. Expert Opin
Biol Ther. 9:1271–1278. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Habib M and Saif MW: Pancreatic cancer
stem cells: Their role in pancreatic cancer patient outcomes and
what is future? JOP. 14:401–404. 2013.PubMed/NCBI
|
|
27
|
Cioffi M, Trabulo SM, Sanchez-Ripoll Y,
Miranda-Lorenzo I, Lonarod E, Dorado J, Vieira Reis C, Ramirez JC,
Hidalgo M, Aicher A, et al: The miR-17-92 cluster counteracts
quiescence and chemoresistance in a distinct subpopulation of
pancreatic cancer stem cell. Gut. 64:1936–1948. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goodell MA, Brose K, Paradis G, Conner AS
and Mulligan RC: Isolation and functional properties of murine
hematopoietic stem cells that are replicating in vivo. J Exp Med.
183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hilton J: Role of aldehyde dehydrogenase
in cyclophosphamide-resistant L1210 leukemia. Cancer Res.
44:5156–5160. 1984.PubMed/NCBI
|
|
30
|
Kim R, Emi M and Tanabe K: Role of
mitochondria as the gardens of cell death. Cancer Chemother
Pharmacol. 57:545–553. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li L, Gu M, You B, Shi S, Shan Y, Bao L
and You Y: Long non-coding RNA ROR promotes proliferation,
migration and chemoresistance of nasopharyngeal carcinoma. Cancer
Sci. 107:1215–1222. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu J, Wan L, Lu K, Sun M, Pan X, Zhang P,
Lu B, Liu G and Wang Z: The long noncoding RNA MEG3 contributes to
cisplatin resistance of human lung adenocarcinoma. PLoS One.
10:e01145862015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of
lncRNAAK126698 on cisplatin resistance in non-small-cell lung
cancer cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
